Suppr超能文献

乳腺良性硬化性病变间质细胞中的角蛋白表达模式:一个潜在的诊断陷阱。

Keratin Expression Patterns in Stromal Cells of Benign Sclerosing Lesions of the Breast: A Potential Diagnostic Pitfall.

作者信息

Oh Eun-Yeong, Collins Laura C

机构信息

From the Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.

出版信息

Arch Pathol Lab Med. 2015 Sep;139(9):1143-8. doi: 10.5858/arpa.2014-0496-OA. Epub 2015 May 19.

Abstract

CONTEXT

Metaplastic carcinomas arising in association with benign sclerosing lesions (BSLs) are rare malignancies in which a neoplastic spindle cell proliferation can be recognized extending beyond the boundaries of the complex sclerosing lesion or papilloma. However, in cases in which the metaplastic carcinoma is of the low-grade fibromatosis-like type or is a low-grade adenosquamous carcinoma, distinction from the background BSL can be a significant challenge. Cytokeratin (CK) and/or p63 immunostains are helpful in confirming the diagnosis of metaplastic carcinoma, but the expression patterns of these markers in the stromal cells of BSLs have not been well characterized.

OBJECTIVE

To characterize the expression patterns of CKs and p63 in BSLs.

DESIGN

We evaluated the spindle cell component of 55 BSLs using CK 5/6, CK 903, CK MNF116, and p63.

RESULTS

A total of 45 cases (81%) showed no staining for CKs or p63 in benign stromal cells. CK 5/6, CK 903, and p63 were positive in one case each. CK MNF116 stained spindle cells within 10 BSLs. No cases showed spindle cell reactivity for all 4 markers. Positive cases demonstrated very focal, weak staining of spindle cells; only 1 case showed focal, moderate CK staining. Spindle cell positivity was not associated with lesion type, growth pattern, spindle cell atypia, or mitoses.

CONCLUSIONS

These findings suggest that although the presence or absence of expression of CK 5/6, CK 903, and p63 may be useful to distinguish BSL from metaplastic carcinomas arising in this setting, CK MNF116 positivity may be a diagnostic pitfall.

摘要

背景

与良性硬化性病变(BSLs)相关的化生性癌是罕见的恶性肿瘤,其中肿瘤性梭形细胞增殖可被识别为超出复杂硬化性病变或乳头状瘤边界。然而,在化生性癌为低级别纤维瘤样类型或低级别腺鳞癌的病例中,与背景BSL进行区分可能是一项重大挑战。细胞角蛋白(CK)和/或p63免疫染色有助于确诊化生性癌,但这些标志物在BSLs基质细胞中的表达模式尚未得到充分描述。

目的

描述CK和p63在BSLs中的表达模式。

设计

我们使用CK 5/6、CK 903、CK MNF116和p63评估了55例BSLs的梭形细胞成分。

结果

总共45例(81%)在良性基质细胞中未显示CK或p63染色。CK 5/6、CK 903和p63各有1例呈阳性。CK MNF116在10例BSLs中对梭形细胞进行了染色。没有病例显示所有4种标志物对梭形细胞均有反应。阳性病例显示梭形细胞呈非常局灶性、弱阳性染色;只有1例显示局灶性、中度CK染色。梭形细胞阳性与病变类型、生长模式、梭形细胞异型性或有丝分裂无关。

结论

这些发现表明,虽然CK 5/6、CK 903和p63表达的有无可能有助于将BSL与在此情况下发生的化生性癌区分开来,但CK MNF116阳性可能是一个诊断陷阱。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验